Table: Mochida Pharm -Q1 group results

Mochida Pharmaceutical

31/07/2020 06:00

Jul 31 (Reuters)- 
             Mochida Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.38               26.49           102.00    
                 (+3.4 pct)          (-11.1 pct)      (+0.2 pct)  
  Operating          4.59                4.52             7.80    
                 (+1.7 pct)          (-26.7 pct)      (-11.4 pct) 
  Recurring          4.74                4.67             8.20    
                 (+1.5 pct)          (-25.8 pct)      (-10.4 pct) 
  Net                3.37                3.31             5.80    
                 (+1.9 pct)          (-43.4 pct)      (+26.1 pct) 
  EPS             86.89 yen           84.25 yen       149.67 yen  
  Ann Div                             80.00 yen        80.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Mochida Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T